<DOC>
	<DOCNO>NCT01891136</DOCNO>
	<brief_summary>This study determine peanut oral immunotherapy ( OIT ) would desensitize tolerize peanut allergic patient peanut order prevent peanut allergic reaction .</brief_summary>
	<brief_title>Oral Peanut Immunotherapy Peanut Allergic Patients</brief_title>
	<detailed_description>The goal proposal develop peanut OIT patient peanut allergic reaction . This approach design utilize extensive knowledge allergen involve peanut hypersensitivity devise immunotherapeutic approach would lower risk anaphylactic reaction would regulate peanut-specific T cell peanut-allergic patient . Previous attempt utilize peanut-specific immunotherapy ( IT ) unsuccessful primarily side effect therapy .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>Subjects 1 16 year age Diagnosed peanut allergy either : 1 ) positive prick skin test peanut , CAP FEIA 15 great history significant clinical symptom within one hour ingestion peanuts 2 ) positive prick skin test peanut , CAP FEIA â‰¥ 7 history clinical reaction peanut ingestion within past 6 month . A family able compliant study visit . Subjects history severe anaphylaxis peanut Subjects medical history would prevent DBPCFC/OFC peanut The medical history would prevent DBPCFC peanut would prior history open peanut challenge patient experience hypotension require fluid resuscitation , respiratory compromise necessitate ventilatory support , poorly control asthma evidence forced expiratory volume 1 second ( FEV1 ) &lt; 80 % predict , FEV1/FVC ( force vital capacity ) &lt; 75 % , without controller medication Subjects unable cooperate challenge procedure unable reach telephone followup Pregnant lactating Allergy oat</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Peanut allergy</keyword>
</DOC>